Drug pipeline updates
Drug Pipeline Quarterly Update: September 2020
Drugs in review, drugs with expiring patents, generic availability and more.
September 30, 2020
These quarterly pipeline wrap-ups include new molecular entity approvals, drugs with approvable status from the FDA, potential blockbuster drugs and the dates of expected FDA approval, names of top selling brand-name drugs with generic availability in the past 12 months and names of top selling brand-name drugs that have patents expiring soon.
Related research
Drug pipeline updates
January 13, 2022
February 2022 decisions expected from the FDA
At Prime Therapeutics (Prime), we’ve positioned ourselves to best prepare our clients to…
Drug pipeline updates
December 31, 2021
Drug Pipeline Quarterly Update: December 2021
These quarterly pipeline wrap-ups include new molecular entity approvals, drugs with approvable status…
Drug pipeline updates
December 11, 2021
January 2022 decisions expected from the FDA
Your monthly synopsis of new drugs expecting FDA decisions in January 2022 At…